CDC Recommends Novavax COVID-19 Vaccine for Adolescents
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax’s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo that Novavax’s COVID-19 vaccine be used as another primary series option for adolescents ages 12 through 17.
A CDC investigation notice update regarding a multistate outbreak of E. coli O157 infections is now live.
A CDC investigation notice regarding a multistate outbreak of <em>E. coli </em>O157 infections is now live: <a href="https://www.cdc.gov/ecoli/2022/o157h7-08-22/index.html">https://www.cdc.gov/ecoli/2022/o157h7-08-22/index.html</a>
Today, CDC is streamlining its COVID-19 guidance to help people better understand their risk, how to protect themselves and others, what actions to take if exposed to COVID-19, and what actions to take if they are sick or test positive for the virus.
Today, the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR), in partnership with the Department of Health and Human Services’ Office of Environmental Justice, announce the release of the <a href="https://eji.cdc.gov">Environmental Justice Index (EJI)</a>.
Today, the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR), in partnership with the Department of Health and Human Services’ Office of Environmental Justice, announce the release of the <a href="https://eji.cdc.gov">Environmental Justice Index (EJI)</a>.
We are deeply saddened by the passing of Tonya Moore. At age 38, Tonya was diagnosed with heart failure because of cigarette smoking.
A new CDC <em>Vital Signs</em> report finds that too few people diagnosed with hepatitis C are being treated, despite availability of medications capable of curing this viral infection
CDC Media Briefing — New Vital Signs Report Hepatitis C is deadly, but curable: Why are so few Americans getting treatment?
Hepatitis C can cause advanced liver disease, liver cancer, and death and affects millions in the United States. Yet, according to a new CDC Vital Signs report, less than a third of people diagnosed with hepatitis C get timely treatment for this curable infection. Join us to learn more about the barriers to hepatitis C..